- Home
- CNEY vs TNON Comparison
CNEY vs TNON Comparison
Compare CNEY & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- TNON
- Stock Information
- Founded
- CNEY 2018
- TNON 2012
- Country
- CNEY China
- TNON United States
- Employees
- CNEY N/A
- TNON N/A
- Industry
- CNEY Major Chemicals
- TNON Medical Specialities
- Sector
- CNEY Industrials
- TNON Health Care
- Exchange
- CNEY Nasdaq
- TNON Nasdaq
- Market Cap
- CNEY 12.9M
- TNON 11.5M
- IPO Year
- CNEY 2021
- TNON 2022
- Fundamental
- Price
- CNEY $2.09
- TNON $1.12
- Analyst Decision
- CNEY
- TNON Strong Buy
- Analyst Count
- CNEY 0
- TNON 2
- Target Price
- CNEY N/A
- TNON $5.50
- AVG Volume (30 Days)
- CNEY 42.1K
- TNON 148.3K
- Earning Date
- CNEY 01-01-0001
- TNON 11-12-2025
- Dividend Yield
- CNEY N/A
- TNON N/A
- EPS Growth
- CNEY N/A
- TNON N/A
- EPS
- CNEY N/A
- TNON N/A
- Revenue
- CNEY $36,049,275.00
- TNON $2,947,000.00
- Revenue This Year
- CNEY N/A
- TNON $43.52
- Revenue Next Year
- CNEY N/A
- TNON $82.14
- P/E Ratio
- CNEY N/A
- TNON N/A
- Revenue Growth
- CNEY N/A
- TNON N/A
- 52 Week Low
- CNEY $1.56
- TNON $0.85
- 52 Week High
- CNEY $21.61
- TNON $5.85
- Technical
- Relative Strength Index (RSI)
- CNEY 39.50
- TNON 41.39
- Support Level
- CNEY $2.08
- TNON $1.15
- Resistance Level
- CNEY $2.36
- TNON $1.22
- Average True Range (ATR)
- CNEY 0.17
- TNON 0.04
- MACD
- CNEY -0.03
- TNON -0.00
- Stochastic Oscillator
- CNEY 0.57
- TNON 18.18
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.